These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10840659)

  • 1. [Drug therapy of heart failure].
    Hennersdorf M; Schwartzkopff B; Strauer BE
    Internist (Berl); 2000 Apr; 41 Suppl 1():S2-12. PubMed ID: 10840659
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of ischemic and nonischemic heart failure. Current status and prospects].
    Weil J; Riegger G
    Internist (Berl); 2002 Apr; 43 Suppl 1():S8, S11-8. PubMed ID: 11993003
    [No Abstract]   [Full Text] [Related]  

  • 3. Digoxin.
    Hampton JR
    Br J Hosp Med; 1997 Oct 1-14; 58(7):321-3. PubMed ID: 9509052
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive inotropic agents in congestive heart failure.
    Homoud MK; Chuttani K; Konstam MA
    Coron Artery Dis; 1993 Jan; 4(1):44-52. PubMed ID: 7903591
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy.
    Stevenson LW
    Circulation; 2003 Jul; 108(4):492-7. PubMed ID: 12885733
    [No Abstract]   [Full Text] [Related]  

  • 6. [Risk factors for dying among ibopamine users].
    de Graeff PA; Elferink AJ; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1999 May; 143(21):1114-5. PubMed ID: 10368748
    [No Abstract]   [Full Text] [Related]  

  • 7. Inotropic therapy for heart failure.
    Stevenson LW
    N Engl J Med; 1998 Dec; 339(25):1848-50. PubMed ID: 9854124
    [No Abstract]   [Full Text] [Related]  

  • 8. Diuretics in the treatment of heart failure: mainstay of therapy or potential hazard?
    Krum H; Cameron P
    J Card Fail; 2006 Jun; 12(5):333-5. PubMed ID: 16762793
    [No Abstract]   [Full Text] [Related]  

  • 9. Ibopamine and survival in severe congestive heart failure: PRIME II.
    Massel D
    Lancet; 1997 Jul; 350(9071):147. PubMed ID: 9228992
    [No Abstract]   [Full Text] [Related]  

  • 10. Design of phase II trials in congestive heart failure.
    DeMets DL
    Am Heart J; 2000 Apr; 139(4):S207-10. PubMed ID: 10740134
    [No Abstract]   [Full Text] [Related]  

  • 11. Digoxin for the treatment of heart failure.
    Hallberg P; Michaëlsson K; Melhus H
    N Engl J Med; 2003 Feb; 348(7):661-3; author reply 661-3. PubMed ID: 12587575
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic heart failure and the quality of life.
    Pritzker MR
    N Engl J Med; 1999 May; 340(19):1511; author reply 1512. PubMed ID: 10328720
    [No Abstract]   [Full Text] [Related]  

  • 13. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? II. Protagonist's viewpoint.
    Packer M
    J Am Coll Cardiol; 1988 Aug; 12(2):562-6. PubMed ID: 3392349
    [No Abstract]   [Full Text] [Related]  

  • 14. [Challenge for the general practitioner. Sufficient therapy for heart failure].
    Füessl HS
    MMW Fortschr Med; 2000 Nov; 142(46):4-8. PubMed ID: 11132311
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inotropic agents in the treatment of congestive heart failure].
    Iizuka M
    Jpn Circ J; 1993; 57 Suppl 4():1363-6. PubMed ID: 7966987
    [No Abstract]   [Full Text] [Related]  

  • 16. Current perspectives on the design of phase II trials of new drugs for the treatment of heart failure.
    Packer M
    Am Heart J; 2000 Apr; 139(4):S202-6. PubMed ID: 10740133
    [No Abstract]   [Full Text] [Related]  

  • 17. Digoxin and mortality in chronic heart failure. UK Heart Investigation.
    Lindsay SJ; Kearney MT; Prescott RJ; Fox KA; Nolan J
    Lancet; 1999 Sep; 354(9183):1003. PubMed ID: 10501370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors for dying among ibopamine users].
    Vandenbroucke JP
    Ned Tijdschr Geneeskd; 1999 Jul; 143(31):1631-2. PubMed ID: 10488378
    [No Abstract]   [Full Text] [Related]  

  • 19. Whither digitalis?
    Campbell RW
    Lancet; 1997 Jun; 349(9069):1854-5. PubMed ID: 9217753
    [No Abstract]   [Full Text] [Related]  

  • 20. Ibopamine and survival in severe congestive heart failure: PRIME II.
    Girbes AR; Zijlstra JG
    Lancet; 1997 Jul; 350(9071):147-8. PubMed ID: 9228993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.